Literature DB >> 15914615

Early adult-onset POAG linked to 15q11-13 using ordered subset analysis.

R Rand Allingham1, Janey L Wiggs, Elizabeth R Hauser, Karen R Larocque-Abramson, Cecilia Santiago-Turla, Bob Broomer, Elizabeth A Del Bono, Felicia L Graham, Jonathan L Haines, Margaret A Pericak-Vance, Michael A Hauser.   

Abstract

PURPOSE: Primary open-angle glaucoma (POAG) is a complex inherited disorder. It has been demonstrated in other complex disorders that phenotypic heterogeneity may be the result of genetic heterogeneity and that stratification analysis can be used to increase the power of detection. Ordered subset analysis (OSA) is a recently described method that utilizes the variability of phenotypic traits to determine underlying genetic heterogeneity.
METHODS: Eighty-six multiplex families with POAG were clinically ascertained for genetic analysis. Age at diagnosis (AAD) was used as a surrogate for age of onset in affected family members. Nine genetic markers within the 15q11-13 interval on chromosome 15 were used for OSA analysis.
RESULTS: An 11-cM linkage interval with a peak LOD score of 3.24 centered at the GABRB3 locus (P = 0.013 by permutation test) was identified in a subset of 15 families, which represents 17% of the total dataset (15/86 families). The mean AAD for the affected OSA families was 44.1 +/- 9.1 years (SD). The mean AAD for the complementary group was 61.3 +/- 10.4 years. African-American and white families were well represented in the OSA subset.
CONCLUSIONS: Linkage was identified for POAG to an 11-cM region on chromosome 15, designated GLC1I. This result provides further evidence that AAD and other phenotypic traits can be used as stratification variables to identify genes in complex disorders such as POAG and suggests that the 15q11-13 locus is one of the largest genetic contributors to POAG identified to date.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914615      PMCID: PMC1389566          DOI: 10.1167/iovs.04-1477

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Genome-wide scan for adult onset primary open angle glaucoma.

Authors:  J L Wiggs; R R Allingham; A Hossain; J Kern; J Auguste; E A DelBono; B Broomer; F L Graham; M Hauser; M Pericak-Vance; J L Haines
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

Review 2.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.

Authors:  R D Nicholls; J L Knepper
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

3.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Authors:  Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

4.  Profile of the genes expressed in the human peripheral retina, macula, and retinal pigment epithelium determined through serial analysis of gene expression (SAGE).

Authors:  Dror Sharon; Seth Blackshaw; Constance L Cepko; Thaddeus P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

5.  A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region.

Authors:  O C Trifan; E I Traboulsi; D Stoilova; I Alozie; R Nguyen; S Raja; M Sarfarazi
Journal:  Am J Ophthalmol       Date:  1998-07       Impact factor: 5.258

6.  Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions.

Authors:  J L Underwood; C G Murphy; J Chen; L Franse-Carman; I Wood; D L Epstein; J A Alvarado
Journal:  Am J Physiol       Date:  1999-08

7.  Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.

Authors:  Sharareh Monemi; George Spaeth; Alexander DaSilva; Samuel Popinchalk; Elena Ilitchev; Jeffrey Liebmann; Robert Ritch; Elise Héon; Ronald Pitts Crick; Anne Child; Mansoor Sarfarazi
Journal:  Hum Mol Genet       Date:  2005-01-27       Impact factor: 6.150

8.  Identification of a gene that causes primary open angle glaucoma.

Authors:  E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

9.  Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A)

Authors:  W L Alward; J H Fingert; M A Coote; A T Johnson; S F Lerner; D Junqua; F J Durcan; P J McCartney; D A Mackey; V C Sheffield; E M Stone
Journal:  N Engl J Med       Date:  1998-04-09       Impact factor: 91.245

10.  The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes.

Authors:  S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

View more
  28 in total

Review 1.  Current gene discovery strategies for ocular conditions.

Authors:  Priya Duggal; Grace Ibay; Alison P Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

2.  The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness.

Authors:  Jac Charlesworth; Patricia L Kramer; Tom Dyer; Victor Diego; John R Samples; Jamie E Craig; David A Mackey; Alex W Hewitt; John Blangero; Mary K Wirtz
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

3.  The Prevalence of Glaucoma in Young People.

Authors:  Susanne Marx-Gross; Dagmar Laubert-Reh; Astrid Schneider; René Höhn; Alireza Mirshahi; Thomas Münzel; Philipp S Wild; Manfred E Beutel; Maria Blettner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

4.  Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE.

Authors:  Catherine Bowes Rickman; Jessica N Ebright; Zachary J Zavodni; Ling Yu; Tianyuan Wang; Stephen P Daiger; Graeme Wistow; Kathy Boon; Michael A Hauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

5.  Ordered-subset analysis (OSA) for family-based association mapping of complex traits.

Authors:  Ren-Hua Chung; Silke Schmidt; Eden R Martin; Elizabeth R Hauser
Journal:  Genet Epidemiol       Date:  2008-11       Impact factor: 2.135

6.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 7.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

8.  Evaluation of SPARC as a candidate gene of juvenile-onset primary open-angle glaucoma by mutation and copy number analyses.

Authors:  Li Jia Chen; Pancy O S Tam; Clement C Y Tham; Xiao Ying Liang; Sylvia W Y Chiang; Oscar Canlas; Robert Ritch; Douglas J Rhee; Chi Pui Pang
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

Review 9.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

10.  Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.

Authors:  Arun Kumar; Manjunath G Basavaraj; Santosh K Gupta; Imteyaz Qamar; Abdullah Mahmood Ali; Vineeta Bajaj; T K Ramesh; D Ravi Prakash; Jyoti S Shetty; Syril K Dorairaj
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.